These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14529262)

  • 21. Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.
    Ahearn EP; Mussey M; Johnson C; Krohn A; Krahn D
    Int Clin Psychopharmacol; 2006 Jan; 21(1):29-33. PubMed ID: 16317314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report.
    Mancini-Marïe A; Fahim C; Potvin S; Beauregard M; Stip E
    Eur Psychiatry; 2006 Dec; 21(8):574-7. PubMed ID: 16140509
    [No Abstract]   [Full Text] [Related]  

  • 23. A model of anticholinergic activity of atypical antipsychotic medications.
    Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
    Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo serotonin 5-HT(2A) receptor occupancy and quetiapine.
    Jones HM; Travis MJ; Mulligan R; Visvikis D; Gacinovic S; Ell PJ; Kerwin RW; Pilowsky LS
    Am J Psychiatry; 2000 Jan; 157(1):148. PubMed ID: 10618043
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antidepressive efficacy of quetiapine XR in unipolar major depression--the role of early onset of action and sleep-improving effect in decreasing suicide risk].
    Rihmer Z
    Neuropsychopharmacol Hung; 2009 Dec; 11(4):211-5. PubMed ID: 20150658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
    Kuroki T; Kaminiwa S; Haeno M; Kohara K; Ninomiya H
    Seishin Shinkeigaku Zasshi; 2004; 106(8):1025-9. PubMed ID: 15655899
    [No Abstract]   [Full Text] [Related]  

  • 27. Early onset of action and sleep-improving effect are crucial in decreasing suicide risk: the role of quetiapine XR in the treatment of unipolar and bipolar depression.
    Pompili M; Rihmer Z; Gonda X; Serafini G; Sher L; Girardi P
    Riv Psichiatr; 2012; 47(6):489-97. PubMed ID: 23160109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine ameliorates anxiety-like behavior and cognitive impairments in stressed rats: implications for the treatment of posttraumatic stress disorder.
    Wang HN; Peng Y; Tan QR; Chen YC; Zhang RG; Qiao YT; Wang HH; Liu L; Kuang F; Wang BR; Zhang ZJ
    Physiol Res; 2010; 59(2):263-271. PubMed ID: 19537923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of second-generation antipsychotic agents for sleep and sedation: a provider survey.
    Hermes ED; Sernyak M; Rosenheck R
    Sleep; 2013 Apr; 36(4):597-600. PubMed ID: 23565006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine in post-transplant acute mania/bipolar disorder NOS.
    Goracci A; Fagiolini A; Calossi S; Santomauro T; Voltolini L; Fossi A; Rottoli P; Castrogiovanni P
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):723-4. PubMed ID: 18346295
    [No Abstract]   [Full Text] [Related]  

  • 31. Sleep-promoting properties of quetiapine in healthy subjects.
    Cohrs S; Rodenbeck A; Guan Z; Pohlmann K; Jordan W; Meier A; Rüther E
    Psychopharmacology (Berl); 2004 Jul; 174(3):421-9. PubMed ID: 15029469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of atypical antipsychotics in mood disorders.
    Weizman R; Weizman A
    Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode.
    Kalelioglu T; Genc A; Karamustafalioglu N; Tasdemir A; Can Gungor F; Cansiz A; Incir S; Cem Ilnem M; Emul M
    Psychiatry Res; 2014 Aug; 218(1-2):249-51. PubMed ID: 24768245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antipsychotic dosing: still a work in progress.
    Remington G
    Am J Psychiatry; 2010 Jun; 167(6):623-5. PubMed ID: 20516160
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of atypical antipsychotics after traumatic brain injury.
    Elovic EP; Jasey NN; Eisenberg ME
    J Head Trauma Rehabil; 2008; 23(2):132-5. PubMed ID: 18362767
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use.
    Ahearn EP; Krohn A; Connor KM; Davidson JR
    Ann Clin Psychiatry; 2003; 15(3-4):193-201. PubMed ID: 14971865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting.
    Kasckow JW; Mulchahey JJ; Mohamed S
    J Am Med Dir Assoc; 2004; 5(4):242-8. PubMed ID: 15228634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting cognition in schizophrenia research: from etiology to treatment.
    Goldberg TE; Gomar JJ
    Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
    [No Abstract]   [Full Text] [Related]  

  • 40. Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair.
    Zhornitsky S; Wee Yong V; Koch MW; Mackie A; Potvin S; Patten SB; Metz LM
    CNS Neurosci Ther; 2013 Oct; 19(10):737-44. PubMed ID: 23870612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.